Strain identifier

BacDive ID: 14464

Type strain: No

Species: Staphylococcus aureus

Strain Designation: F-182

Culture col. no.: DSM 13661, ATCC 43300, CCUG 41586, LMG 15975, WDCM 00211

Strain history: <- CCUG; CCUG 41586 <- BCCM; LMG 15975 <- ATCC; ATCC 43300 <- C. Thornsberry; F-182

NCBI tax ID(s): 1280 (species)

« Browse strain by BacDive ID »

expand / minimize allblue arrow down

Exclude non-curated data/information

Staphylococcus aureus F-182 is a mesophilic human pathogen that has multiple antibiotic resistances and was isolated from human clinical.

  1. antibiotic resistance
  2. human pathogen
  3. mesophilic
  4. 16S sequence
  5. Bacteria
  6. genome sequence
  • Availability in culture collections External linksarrow_down
  • [Ref.: #5032] Culture collection no. DSM 13661, ATCC 43300, CCUG 41586, LMG 15975, WDCM 00211
    [Ref.: #20218] Associated Passport(s) in StrainInfo 163782, 54914, 163783, 54913, 898931
    Literature: Only first 10 entries are displayed. Click here to see all.Click here to see only first 10 entries.
    Topicarrow to sort Titlearrow to sort Authorsarrow to sort Journalarrow to sort DOIarrow to sort Yeararrow to sort
    Pathogenicity Optimal inoculation methods and quality control for the NCCLS oxacillin agar screen test for detection of oxacillin resistance in Staphylococcus aureus. Swenson JM, Spargo J, Tenover FC, Ferraro MJ J Clin Microbiol 10.1128/JCM.39.10.3781-3784.2001 2001 *
    Enzymology Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis. Sipahi OR, Arda B, Yurtseven T, Sipahi H, Ozgiray E, Suntur BM, Ulusoy S Int J Antimicrob Agents 10.1016/j.ijantimicag.2005.08.011 2005 *
    Pathogenicity Antimicrobial activity screening of some sulfonamide derivatives on some Nocardia species and isolates. Isik K, Ozdemir-Kocak F Microbiol Res 10.1016/j.micres.2006.11.002 2007 *
    Enzymology Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model. Lubenko IY, Strukova EV, Smirnova MV, Vostrov SN, Portnoy YA, Zinner SH, Firsov AA J Antimicrob Chemother 10.1093/jac/dkn288 2008 *
    Enzymology Linezolid pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model. Strukova EN, Smirnova MV, Vostrov SN, Lubenko IY, Firsov AA, Zinner SH, Portnoy YA Int J Antimicrob Agents 10.1016/j.ijantimicag.2008.09.006 2008 *
    Pathogenicity The impact of duration of antibiotic exposure on bacterial resistance predictions using in vitro dynamic models. Smirnova MV, Vostrov SN, Strukova EV, Dovzhenko SA, Kobrin MB, Portnoy YA, Zinner SH, Firsov AA J Antimicrob Chemother 10.1093/jac/dkp287 2009 *
    Pathogenicity Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). Karska-Wysocki B, Bazo M, Smoragiewicz W Microbiol Res 10.1016/j.micres.2009.11.008 2010 *
    Metabolism Evaluation of Vancoplus versus ceftriaxone against cephalosporin resistance MRSA strain in experimental meningitis model. Soni A, Chaudhary M, Dwivedi VK, Kumar S, Shrivastava SM Cardiovasc Hematol Disord Drug Targets 10.2174/187152910791292466 2010 *
    Pathogenicity Inhibition of methicillin-resistant Staphylococcus aureus by the compound Qingre granules. Yu YY, Wang H, Zhang SW, Wang BE Chin Med J (Engl) 2010 *
    Pathogenicity Superhydrophilicity and antibacterial property of a Cu-dotted oxide coating surface. Nie Y, Kalapos C, Nie X, Murphy M, Hussein R, Zhang J Ann Clin Microbiol Antimicrob 10.1186/1476-0711-9-25 2010 *

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Field you want to change:

CAPTCHAReload captcha

Change proposal

Successfully sent